Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercial Agreement For Iclusig (Ponatinib) In Israel
8/5/2014 10:40:47 AM
CAMBRIDGE, Mass. & PETACH TIKVA, Israel--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Medison Pharma Ltd, Israel's leading international marketing group for innovative pharmaceuticals, today announced that ARIAD has granted Medison exclusive rights to commercialize Iclusig® (ponatinib) in Israel in patients with Philadelphia-positive (Ph+) leukemias.
Help employers find you! Check out all the jobs and post your resume.
comments powered by